Watch CI. Know when insiders buy.
One email the day a filing lands. Free.
Work order
27
FLAG · insiders 27, shorts 27
Insiders, 90 days
−$749K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
5 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $74.7BP/E 11.7DIV YIELD 2.17%FCF YIELD —REV TTM $282.4B +7.8%NET INCOME $6.2B +27.9%NET DEBT $22.8B52W 244.41 – 311.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $71.7B | +6.7% | 20.9% | $2.7B | $1.7B | +8.4% | 6.29 | −$421M | — | — | Jul 30 |
| Q1 2026 · Mar 31 | $68.5B | +4.6% | 21.0% | $2.4B | $1.7B | +25.0% | 6.26 | $1.1B | — | — | Apr 30 |
| Q4 2025 · Dec 31derived | $72.5B | +10.4% | 20.3% | $2.3B | $943M | −20.9% | 4.66 | $6.1B | — | — | Feb 26 |
| Q3 2025 · Sep 30 | $69.7B | +9.5% | 20.4% | $2.6B | $2B | +139.2% | 6.98 | $3.4B | — | — | Oct 30 |
| Q2 2025 · Jun 30 | $67.2B | +11.0% | 20.7% | $2.3B | $1.5B | −6.0% | 5.71 | −$1.9B | — | — | Jul 30 |
| Q1 2025 · Mar 31 | $65.5B | +14.4% | 26.1% | $2B | $1.3B | — | 4.85 | $1.9B | — | — | Apr 30 |
| Q4 2024 · Dec 31derived | $65.6B | +28.4% | 25.3% | $2.2B | $1.2B | +32.6% | 5.07 | $5.2B | — | — | Feb 26 |
| Q3 2024 · Sep 30 | $63.7B | +29.9% | 25.3% | $2.6B | $825M | −43.1% | 2.63 | $46M | — | — | Oct 30 |
| Q2 2024 · Jun 30 | $60.5B | — | 26.5% | $2.4B | $1.6B | — | 5.45 | $265M | — | — | Jul 31 |
| Q1 2024 · Mar 31 | $57.3B | — | 27.6% | $2.3B | −$212M | — | -0.97 | $4.8B | — | — | May 2 |
| Q4 2023 · Dec 31 | $51.1B | — | 31.0% | $2.1B | $899M | — | 3.50 | $1.5B | — | — | Feb 26 |
| Q3 2023 · Sep 30 | $49B | — | 31.4% | $2.2B | $1.4B | — | 4.74 | $2.8B | — | — | Oct 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $274.9B | 21.8% | $9.2B | $6B | 2.2% | 22.18 | $9.6B | — | — | $3.6B | $1.6B |
| FY2024 · to Dec 31 | $247.1B | 26.1% | $9.4B | $3.4B | 1.4% | 12.12 | $10.4B | — | — | $7B | $1.6B |
| FY2023 · to Dec 31 | $195.3B | 31.5% | $8.5B | $5.2B | 2.6% | 17.39 | $11.8B | — | — | $2.3B | $1.4B |
| FY2022 · to Dec 31 | $180.5B | 30.8% | $8.4B | $6.8B | 3.8% | 21.41 | $8.7B | — | — | $7.6B | $1.4B |
| FY2021 · to Dec 31 | $174.1B | 32.5% | $7.9B | $5.4B | 3.1% | 15.75 | $7.2B | — | — | $7.7B | $1.3B |
| FY2020 · to Dec 31 | $160.4B | 35.5% | $8.2B | $8.5B | 5.3% | 22.96 | $10.3B | — | — | $4B | $15M |
Every number comes from Cigna Group's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.